-+ 0.00%
-+ 0.00%
-+ 0.00%

Lianya Pharmaceutical and General Conway Shenzhen Stock Exchange IPO review status changed to “Submit for Registration”

Zhitongcaijing·07/10/2026 12:57:10
Listen to the news

The Zhitong Finance App learned that on July 10, companies such as Lianya Pharmaceutical and Tongze Conway changed their IPO review status to “submit registration” on the Shenzhen Stock Exchange.

WeChat photo_20260710203652_14860_83.png

The sponsor of Lianya Pharmaceutical is CICC, which plans to raise 950 million yuan. According to the prospectus, Lianya Pharmaceutical is an R&D-driven high-tech enterprise, mainly engaged in R&D, production and sales of complex pharmaceutical preparations. The company's current products include different types of controlled release formulations and two types of high-end generic drugs represented by low-dose pharmaceutical preparations, which are currently mainly used in the fields of hypertension, coronary artery disease, diabetes, schizophrenia, female contraception and health; at the same time, the company also provides CRO and other services to pharmaceutical companies and R&D institutions with leading drug design capabilities and formulation process technology; during the reporting period, the company mainly sold to the US market, and many products had the highest share in the US market.

In general, Conway's sponsor is CITIC Construction Investment, which plans to raise 1,3811.1 billion yuan. According to the prospectus, according to the prospectus, Conway is mainly engaged in the design, development, production and sale of independent models of broadband connection terminal devices, mainly directly providing products and services to global telecom operators, and actively expanding customer applications in vertical industries. According to the global 5G FWA CPE supplier competitiveness ranking released by ABI Research (a world-renowned technology intelligence company) in January 2025, Conway is generally ranked 7th in the world. Apart from ZTE and Huawei, it is the only broadband connection terminal equipment provider in mainland China to enter the top ten global competitiveness rankings (the rest are European and American companies or Taiwanese companies).